Shopping Cart
- Remove All
Your shopping cart is currently empty
Vandetanib Fumarate is an orally available tyrosine kinase inhibitor. Vandetanib Fumarate works by blocking RET (REarranged during Transfection), vascular endothelial growth factor receptor (VEGFR-2, VEGFR-3), and epidermal growth factor receptor and to a lesser extent VEGFR-1, which are important targets in thyroid cancer (TC).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,670 | 1-2 weeks | |
| 50 mg | $2,180 | 1-2 weeks | |
| 100 mg | $2,800 | 1-2 weeks |
| Description | Vandetanib Fumarate is an orally available tyrosine kinase inhibitor. Vandetanib Fumarate works by blocking RET (REarranged during Transfection), vascular endothelial growth factor receptor (VEGFR-2, VEGFR-3), and epidermal growth factor receptor and to a lesser extent VEGFR-1, which are important targets in thyroid cancer (TC). |
| Synonyms | ZD 6474, Zactima, Vandetanib, HSDB 8198, Caprelsa |
| Molecular Weight | 591.43 |
| Formula | C26H28BrFN4O6 |
| Cas No. | 338992-00-0 |
| Relative Density. | 1.406 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.